Eight original articles, ranging from in vitro to animal models and human clinical research, explore various nutrition-focused themes that include probiotics, symbiotics, vitamin D, dietary intake and composition, protein dosing, obesity, myopenia, and exclusive enteral nutrition on diverse IBD outcomes [4, [10] [11] [12] [13] [14] [15] [16] .
Vidal-Lletjos et al. identified that moderately high protein dosing modulated mucosal healing, however high the protein intake, had deleterious consequences in animal models [14] . These results are undoubtedly of interest for developing nutrition prescriptions in the clinical setting and require further study in human populations. Taylor et al. described suboptimal dietary intake and low adherence with Mediterranean diet guidelines as not keeping with anti-inflammatory dietary patterns [4] . Shinde et al. demonstrated that symbiotic supplementation ameliorated disease activity index and histological scores in animal models, warranting human trials [12] . Of interest, Bryant et al. determined that, over 24 months of longitudinal follow-up, the body composition of patients with IBD changed, with gains of fat mass but decreases in lean muscle mass [16] . The morbidity that may be associated with these findings deserves further attention.
These valuable manuscripts contribute toward advancing knowledge about current dietary intake and composition in patients with IBD, describe existing nutritional deficiencies including myopenia, and provide a platform of nutritional supplements with biologic plausibility to be subjected to further trials.
We believe this compendium is a useful summary of the nutrition progress in IBD. The need for further nutrition intervention trials with diets that are mechanistically sensible and address the industrialization of food remains as a loud unspoken statement.
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